The V617F mutation in Jak2 is not found in childhood acute lymphoblastic leukaemia

被引:29
作者
Sulong, S
Case, M
Minto, L
Wilkins, B
Hall, A
Irving, J [1 ]
机构
[1] No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
关键词
childhood acute lymphoblastic leukaemia; Jak2; mutation;
D O I
10.1111/j.1365-2141.2005.05697.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:964 / 965
页数:2
相关论文
共 8 条
  • [1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    Baxter, EJ
    Scott, LM
    Campbell, PJ
    East, C
    Fourouclas, N
    Swanton, S
    Vassiliou, GS
    Bench, AJ
    Boyd, EM
    Curtin, N
    Scott, MA
    Erber, WN
    Green, AR
    [J]. LANCET, 2005, 365 (9464) : 1054 - 1061
  • [2] Carron C, 2000, BLOOD, V95, P3891
  • [3] Genomic organization of human JAK2 and mutation analysis of its JH2-domain in leukemia
    Cools, J
    Peeters, P
    Voet, T
    Aventin, A
    Meeucci, C
    Grandchamp, B
    Marynen, P
    [J]. CYTOGENETICS AND CELL GENETICS, 1999, 85 (3-4): : 260 - 266
  • [4] A gain-of-function mutation of JAK2 in myeloproliferative disorders
    Kralovics, R
    Passamonti, F
    Buser, AS
    Teo, S
    Tiedt, R
    Passweg, JR
    Tichelli, A
    Cazzola, M
    Skoda, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) : 1779 - 1790
  • [5] A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
    Lacronique, V
    Boureux, A
    DellaValle, V
    Poirel, H
    Quang, CT
    Mauchauffe, M
    Berthou, C
    Lessard, M
    Berger, R
    Ghysdael, J
    Bernard, OA
    [J]. SCIENCE, 1997, 278 (5341) : 1309 - 1312
  • [6] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
    Levine, RL
    Wadleigh, M
    Cools, J
    Ebert, BL
    Wernig, G
    Huntly, BJP
    Boggon, TJ
    Wlodarska, L
    Clark, JJ
    Moore, S
    Adelsperger, J
    Koo, S
    Lee, JC
    Gabriel, S
    Mercher, T
    D'Andrea, A
    Fröhling, S
    Döhner, K
    Marynen, P
    Vandenberghe, P
    Mesa, RA
    Tefferi, A
    Griffin, JD
    Eck, MJ
    Sellers, WR
    Meyerson, M
    Golub, TR
    Lee, SJ
    Gilliland, DG
    [J]. CANCER CELL, 2005, 7 (04) : 387 - 397
  • [7] Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
    Meydan, N
    Grunberger, T
    Dadi, H
    Shahar, M
    Arpaia, E
    Lapidot, Z
    Leeder, JS
    Freedman, M
    Cohen, A
    Gazit, A
    Levitzki, A
    Roifman, CM
    [J]. NATURE, 1996, 379 (6566) : 645 - 648
  • [8] Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia
    Peeters, P
    Raynaud, SD
    Cools, J
    Wlodarska, I
    Grosgeorge, J
    Philip, P
    Monpoux, F
    VanRompaey, L
    Baens, M
    VandenBerghe, H
    Marynen, P
    [J]. BLOOD, 1997, 90 (07) : 2535 - 2540